InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-16.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Langer Dennis, Director. Director active across 3 companies, notably Myriad Genetics INC. Cumulatively, 7 disclosures have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €111k. History available since 3 June 2021. The latest transaction was filed on 27 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Langer Dennis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
34,534 shares@ US$5.15ADSsSEC:0001104659-26-103376:0
15,152 shares@ US$8.4999.8% of flowADSsSEC:0001104659-25-099782:0
Canonical exit: 12 Jan 2026 (T+90)
297 shares@ US$0.732100.0% of flowOrdinary SharesSEC:0001104659-24-070017:0
17,275 shares0Common StockSEC:0001628280-22-016225:0
30,000 shares@ US$25.39100.0% of flowCommon StockSEC:0001274225-21-000004:0
12,848 shares0Common StockSEC:0001274225-21-000002:0
34,722 sharesCommon StockSEC:0000899243-16-012748:0
7 of 7 declarations
About Langer Dennis
LANGER DENNIS is Administrateur and is reported for Myriad Genetics INC, Quoin Pharmaceuticals, Ltd. and Dicerna Pharmaceuticals Inc. He has 6 filings in total, and across the sampled recent filings from 2016-02-05 to 2025-10-15, the buy amount is EUR 110875 and the sell amount is EUR 200; the most frequent transaction nature is Attribution.
